COMP <GO>
AVAH vs OPCH // EV/EBITDA & P/E VALUATION
Aveanna Healthcare Holdings Inc. (NASDAQ) VS. Option Care Health Inc. (NASDAQ) • 15-METRIC TALLY: AVAH 5
— OPCH 6
▲ EV/EBITDA & P/E VALUATION LEADER: OPCH
LAST: $13.16 (-0.75%) • MKT CAP: $2.87B
valuation
15.5x
LAST: $31.83 (-0.06%) • MKT CAP: $4.77B
valuation
15.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVAH VS. OPCH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVAH | OPCH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 33.30% | 19.30% | +14.00 | AVAH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 15.70% | 11.90% | +3.80 | AVAH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 15.5x | 15.3x | +0.20 | OPCH | /valuation <GO> |
| Free Cash Flow Yield | 4.35% | 4.55% | -0.20 | OPCH | /fcf-yield <GO> |
| Operating Margin | 10.50% | 6.00% | +4.50 | AVAH | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 3.70% | -3.70 | OPCH | /net-margins <GO> |
| Revenue Growth (YoY) | 20.20% | 13.00% | +7.20 | AVAH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.86 | 3.81 | -1.95 | OPCH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | AVAH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.5 | 83.8 | -28.30 | OPCH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.10 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 19.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.87B | $4.77B | -$1.90B | OPCH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVAH REV | OPCH REV | AVAH GROSS % | OPCH GROSS % | AVAH FCF | OPCH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.43B | $5.65B | 33.3% | 19.3% | $125.9M | $217.1M |
| FY 2024 | $2.02B | $5.00B | 31.4% | 20.3% | $32.6M | $287.8M |
| FY 2023 | $1.90B | $4.30B | — | — | $22.7M | $177.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVAH // BETA —
OPCH // BETA 1.10